Biotech | April 20, 2026
Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The innovation is particularly suited for bone and cartilage repair
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Move strengthens footprint in Western India and expands multi-specialty care network
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Subscribe To Our Newsletter & Stay Updated
